Semaglutide: 

In 3 separate clinical trials involving non-diabetic patients, individuals who received a prescription medication containing semaglutide at a dose of 2.4 mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 15% of their body weight over the course of 68 weeks. 

Source

Tirzepatide: 

In a double-blind, randomized, controlled trial, individuals who received a prescription medication containing regular tirzepatide at a dose of 15mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 26.6% over the course of 72 weeks.  

Source

Note: Compounded drugs are formulated for each individual patient and therefore, there have been no studies based on any particular compounded drug.  However, there are studies regarding similar prescription medications that use similar ingredients. These studies do not include research on any particular compounded medication that may be prescribed by a physician on the Qyral platform. No claims can be made as to the safety and effectiveness of any compounded medication for any particular indication or use.